"Genetic Technologies Limited today announced the appointment of Mr. Mark Ostrowski as Senior Vice President Sales & Marketing Molecular Diagnostics. In this role, Mark will be responsible for managing the U.S. sales effort for BREVAGen™, the Company’s cornerstone commercial product. Mark brings to Genetic Technologies over 20 years of sales and marketing experience in molecular diagnostics having served in senior managerial positions at companies focused on women’s health and oncology, including as Director of Sales Operations at Myriad Genetics (NASDAQ: MYGN) and Director of Managed Care Services at DIANON Systems (NASDAQ: DIAN)."
Nice piece of talent.
All the cards are arranging nicely...
:-)
nice appointment
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
